Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Talineuren (InnoMedica)
- Development stage
- Unknown
- Lead developer
- InnoMedica
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
Talineuren (TLN-1) is a liposomal formulation of GM1 ganglioside (monosialotetrahexosylganglioside) developed by InnoMedica. Utilizing a proprietary lipid nanoparticle technology platform, the drug is designed to cross the blood-brain barrier and improve the biodistribution of GM1, a glycosphingolipid naturally found in neuronal cell membranes. GM1 exhibits neuroprotective, neurorestorative, and neurotrophic properties by stabilizing cell membranes and modulating signaling pathways involved in neuronal survival. Talineuren is primarily being developed for neurodegenerative disorders, including Parkinson's disease and Amyotrophic Lateral Sclerosis (ALS), aiming to provide a more effective delivery mechanism and reduced treatment frequency compared to traditional GM1 administration.
- Other names
- GM1-GangliosideGM-1-GangliosideGM 1-Gangliosidemonosialotetrahexosylganglioside
02
Targets
GM1 (GM1 ganglioside)
Beyond the preview
Go deeper on Talineuren (InnoMedica).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Talineuren (InnoMedica).